615 related articles for article (PubMed ID: 15275698)
1. Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial.
Coppola G; Iervolino G; Mastrosimone M; La Torre G; Ruiu F; Pascotto A
Brain Dev; 2004 Sep; 26(6):373-6. PubMed ID: 15275698
[TBL] [Abstract][Full Text] [Related]
2. Endogenous melatonin predicts efficacy of exogenous melatonin in consolidation of fragmented wrist-activity rhythm of adult patients with developmental brain disorders: a double-blind, placebo-controlled, crossover study.
Laakso ML; Lindblom N; Leinonen L; Kaski M
Sleep Med; 2007 Apr; 8(3):222-39. PubMed ID: 17368097
[TBL] [Abstract][Full Text] [Related]
3. Melatonin treatment in individuals with intellectual disability and chronic insomnia: a randomized placebo-controlled study.
Braam W; Didden R; Smits M; Curfs L
J Intellect Disabil Res; 2008 Mar; 52(Pt 3):256-64. PubMed ID: 18261024
[TBL] [Abstract][Full Text] [Related]
4. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities.
Wasdell MB; Jan JE; Bomben MM; Freeman RD; Rietveld WJ; Tai J; Hamilton D; Weiss MD
J Pineal Res; 2008 Jan; 44(1):57-64. PubMed ID: 18078449
[TBL] [Abstract][Full Text] [Related]
5. Melatonin and sleep disorders associated with intellectual disability: a clinical review.
Sajith SG; Clarke D
J Intellect Disabil Res; 2007 Jan; 51(Pt 1):2-13. PubMed ID: 17181598
[TBL] [Abstract][Full Text] [Related]
6. Add-on melatonin improves quality of life in epileptic children on valproate monotherapy: a randomized, double-blind, placebo-controlled trial.
Gupta M; Aneja S; Kohli K
Epilepsy Behav; 2004 Jun; 5(3):316-21. PubMed ID: 15145300
[TBL] [Abstract][Full Text] [Related]
7. Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementia.
Serfaty M; Kennell-Webb S; Warner J; Blizard R; Raven P
Int J Geriatr Psychiatry; 2002 Dec; 17(12):1120-7. PubMed ID: 12461760
[TBL] [Abstract][Full Text] [Related]
8. Long-term effectiveness outcome of melatonin therapy in children with treatment-resistant circadian rhythm sleep disorders.
Carr R; Wasdell MB; Hamilton D; Weiss MD; Freeman RD; Tai J; Rietveld WJ; Jan JE
J Pineal Res; 2007 Nov; 43(4):351-9. PubMed ID: 17910603
[TBL] [Abstract][Full Text] [Related]
9. [Melatonin treatment of sleep disorders in disabled children].
Ramstad K; Loge JH
Tidsskr Nor Laegeforen; 2002 Apr; 122(10):1009-11. PubMed ID: 12082692
[TBL] [Abstract][Full Text] [Related]
10. Melatonin treatment in adolescents with delayed sleep phase syndrome.
Szeinberg A; Borodkin K; Dagan Y
Clin Pediatr (Phila); 2006 Nov; 45(9):809-18. PubMed ID: 17041168
[TBL] [Abstract][Full Text] [Related]
11. Melatonin and sleep-related problems in children with intractable epilepsy.
Elkhayat HA; Hassanein SM; Tomoum HY; Abd-Elhamid IA; Asaad T; Elwakkad AS
Pediatr Neurol; 2010 Apr; 42(4):249-54. PubMed ID: 20304327
[TBL] [Abstract][Full Text] [Related]
12. Melatonin treatment effects on adolescent students' sleep timing and sleepiness in a placebo-controlled crossover study.
Eckerberg B; Lowden A; Nagai R; Akerstedt T
Chronobiol Int; 2012 Nov; 29(9):1239-48. PubMed ID: 23005039
[TBL] [Abstract][Full Text] [Related]
13. Melatonin treatment for circadian rhythm sleep disorders.
Kamei Y; Hayakawa T; Urata J; Uchiyama M; Shibui K; Kim K; Kudo Y; Okawa M
Psychiatry Clin Neurosci; 2000 Jun; 54(3):381-2. PubMed ID: 11186123
[TBL] [Abstract][Full Text] [Related]
14. Levetiracetam for people with mental retardation and refractory epilepsy.
Kelly K; Stephen LJ; Brodie MJ
Epilepsy Behav; 2004 Dec; 5(6):878-83. PubMed ID: 15582836
[TBL] [Abstract][Full Text] [Related]
15. A randomized double-blind placebo-controlled trial of treatment as usual plus exogenous slow-release melatonin (6 mg) or placebo for sleep disturbance and depressed mood.
Serfaty MA; Osborne D; Buszewicz MJ; Blizard R; Raven PW
Int Clin Psychopharmacol; 2010 May; 25(3):132-42. PubMed ID: 20195158
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
[TBL] [Abstract][Full Text] [Related]
17. Effect of melatonin on seizure frequency in intractable epilepsy: a pilot study.
Goldberg-Stern H; Oren H; Peled N; Garty BZ
J Child Neurol; 2012 Dec; 27(12):1524-8. PubMed ID: 22378657
[TBL] [Abstract][Full Text] [Related]
18. Melatonin for chronic insomnia in Angelman syndrome: a randomized placebo-controlled trial.
Braam W; Didden R; Smits MG; Curfs LM
J Child Neurol; 2008 Jun; 23(6):649-54. PubMed ID: 18539989
[TBL] [Abstract][Full Text] [Related]
19. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia.
Van der Heijden KB; Smits MG; Van Someren EJ; Ridderinkhof KR; Gunning WB
J Am Acad Child Adolesc Psychiatry; 2007 Feb; 46(2):233-41. PubMed ID: 17242627
[TBL] [Abstract][Full Text] [Related]
20. Melatonin for sleep disturbances in Parkinson's disease.
Dowling GA; Mastick J; Colling E; Carter JH; Singer CM; Aminoff MJ
Sleep Med; 2005 Sep; 6(5):459-66. PubMed ID: 16084125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]